Please login to the form below

Not currently logged in
Email:
Password:

The Grey Healthcare Group Award for Excellence in Health Improvement and Education

Sponsored by

Finalist

Meningitis Matters

Novartis Vaccines and Diagnostics Limited in association with Ruder Finn UK


Summary of work

Meningitis is the most feared infectious disease among parents in the UK, however, seven out of 10 adults are unaware their children are not protected against all causes of this devastating disease. Inconsistency in media reporting has led to a worrying lack of awareness and understanding. 

To tackle this lack of knowledge, the agency used multiple media platforms to communicate that there is currently no protection against the meningitis-causing meningococcal B bacteria and underline the need for continued vigilance for meningitis symptoms in children. 

The agency developed the Meningitis Matters campaign to engage both ends of the stakeholder spectrum, from parents on the ground to agents of change in government, to communicate these important public health messages. 

In only six months, the campaign evolved how the media reported on meningitis, with more than 200 million on-message media impressions reaching in excess of three times the UK population.

 

 

Executive summary as submitted


PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...

Infographics